These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23038969)

  • 1. [The specific features of renal lesion in Burkitt's lymphoma].
    Lukina AE; Bariakh EA; Kravchenko SK; Biriukova LS; Gemdzhian ÉG; Magomedova AU; Kremenetskaia AM; Vorob'ev AI
    Ter Arkh; 2012; 84(7):31-4. PubMed ID: 23038969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
    Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-dose therapy of Burkitt's lymphoma in patients over 40 years of age].
    Kravchenko SK; Bariakh EA; Zamiatina VI; Perestoronina TN; Fink OS; Gubkin AV; Egorova EK; Zvonkov EE; Iliushkina EA; Krasil'nikova BB; Morozova AK; Vorob'ev IA; Kaplanskaia IB; Kliasova GA; Obukhova TN; Kremenetskaia AM; Vorob'ev AI
    Ter Arkh; 2008; 80(7):9-18. PubMed ID: 18763588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials.
    Seidemann K; Meyer U; Jansen P; Yakisan E; Rieske K; Führer M; Kremens B; Schrappe M; Reiter A
    Klin Padiatr; 1998; 210(4):279-84. PubMed ID: 9743966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy for Burkitt's lymphoma according to the BL-M-04 protocol: 12-year experience].
    Baryakh EA; Tyurina NG; Vorobyev VI; Gemdzhyan EG; Mangasarova YK; Klyasova GA; Kovrigina AM; Obukhova TN; Zvonkov EE; Vernyuk MA; Chervontseva AM; Polyakov YY; Misyurina АЕ; Valiev TT; Zherebtsova VA; Magomedova AU; Galstyan GM; Yatskov KV; Nesterova ES; Vorobyev AI; Kravchenko SK
    Ter Arkh; 2015; 87(7):4-14. PubMed ID: 26390720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
    Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
    Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of conservative treatment of gastric lymphosarcoma].
    Zvonkov EE; Kremenetskaia AM; Kravchenko SK; Makhinia VA; Kaplanskaia IB; Obukhova TN; Samoĭlova RS; Shevelev AA; Magomedova AU; Bariakh EA; Krasil'nikova BB; Gubkin AV; Iliushkina EA; Mar'in DS; Morozova AK; Kulikov SM; Gemdzhian EG; Vorob'ev AI
    Ter Arkh; 2008; 80(7):18-26. PubMed ID: 18763589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and epidemiological features of Burkitt's lymphoma].
    Bariakh EA; Kravchenko SK; Kremenetskaia AM; Zvonkov EE; Obukhova TN; Magomedova AU; Vorob'ev AI
    Ter Arkh; 2009; 81(7):47-53. PubMed ID: 19708573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2000 Burkitt lymphoma trial in Malawi.
    Hesseling P; Broadhead R; Mansvelt E; Louw M; Wessels G; Borgstein E; Schneider J; Molyneux E
    Pediatr Blood Cancer; 2005 Mar; 44(3):245-50. PubMed ID: 15547922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of 40 children with Burkitt's and Burkitt-like lymphoma].
    Zhang YH; Duan YL; Yang J; Jin L; Zhou CJ; Gao ZF
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):209-14. PubMed ID: 19099711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphoma.
    Pohlen M; Gerth HU; Liersch R; Koschmieder S; Mesters RM; Kessler T; Appelmann I; Müller-Tidow C; Berdel WE
    Am J Hematol; 2011 Dec; 86(12):E61-4. PubMed ID: 21898532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massive therapy and autologous bone marrow transplantation in very bad prognosis Burkitt's lymphoma.
    Philip T; Biron P; Philip I; Favrot M; Souillet G; Philippe N; Hervé P; Plouvier E; Bernard JL; Raybaud C
    IARC Sci Publ; 1985; (60):419-34. PubMed ID: 3905593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).
    Ribera JM; García O; Grande C; Esteve J; Oriol A; Bergua J; González-Campos J; Vall-Llovera F; Tormo M; Hernández-Rivas JM; García D; Brunet S; Alonso N; Barba P; Miralles P; Llorente A; Montesinos P; Moreno MJ; Hernández-Rivas JÁ; Bernal T
    Cancer; 2013 May; 119(9):1660-8. PubMed ID: 23361927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute renal failure in African children with Burkitt's lymphoma: a comparison of two treatment regimens.
    Olowu WA; Elusiyan JB; Badejo SA; Adenowo OA
    Pediatr Blood Cancer; 2006 Apr; 46(4):446-53. PubMed ID: 16206217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia.
    Park YH; Kim WS; Kang HJ; Na II; Ryoo BY; Yang SH; Lee SS; Uhm JE; Kim K; Jung CW; Park K; Ko YH
    Ann Hematol; 2006 May; 85(5):285-90. PubMed ID: 16518604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
    Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined chemotherapy for hemoblastoses and therapy for acute respiratory failure in intensive care conditions].
    Galstian GM; Kesel'man SA; Gorodetskiĭ VM; Aleksanian MZh; Kulikov SM; Gemdzhian EG; Parovichnikova EN; Savchenko VG; Vorob'ev AI
    Ter Arkh; 2009; 81(12):37-43. PubMed ID: 20481047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
    Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
    Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Maxillofacial location of Burkitt's lymphoma in children treated at the University Hospital Center in Bamako, Mali: a 24-case series].
    Togo B; Keita M; Medefo D; Traore F; Sidibe T
    Med Trop (Mars); 2008 Dec; 68(6):600-2. PubMed ID: 19639827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.